Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Discover 'Trick' Steroids That Can Suppress Inflammation

January 14, 2015 12:16 pm | by Georgia State University | News | Comments

These drugs could be used to make new anti-inflammatory drugs without the harmful side effects of steroids. Read more...                        


Possible Treatments Found for Highly Contagious Norovirus

January 14, 2015 12:05 pm | by Michael C. Purdy, Washington University in St. Louis | News | Comments

New evidence in mice suggests antibiotics may help fight norovirus. Read more...                              


No Sign of Ebola in CDC Worker Feared Exposed Weeks Ago

January 14, 2015 9:37 am | by Mike Stobbe - AP Medical Writer | News | Comments

Ebola symptoms usually strike within three weeks of infection. Read more...                               


Study Reveals Lack of Data on Opioid Drugs

January 14, 2015 9:35 am | by University of Connecticut | News | Comments

Many of the studies used to justify the prescription of these drugs were either poorly conducted or of an insufficient duration. Read more...                    


Novartis, Qualcomm Create Investment Company for Digital Health

January 14, 2015 9:28 am | News | Comments

Digital and mobile technologies are expected to make a significant difference in the pharmaceutical industry. Read more...                       


Roche, Meiji and Fedora Team Up to Tackle Bacterial Resistance to Antibiotics

January 14, 2015 9:22 am | News | Comments

The three pharmaceutical companies entered into a license agreement for the development and commercialization of a new inhibitor. Read more...                    


How to Predict Responses to Disease

January 14, 2015 9:12 am | by David L. Chandler - MIT | News | Comments

Computer model could help public health officials anticipate overreactions to disease outbreaks. Read more...                         


Tumor Micro-Environment: Rough for Nanoparticle Cancer Drugs

January 13, 2015 5:10 pm | by University of North Carolina at Chapel Hill | News | Comments

Nanoparticle drugs—tiny containers packed with medicine and with the potential to be shipped straight to tumors—were thought to be a possible silver bullet against cancer. However new cancer drugs based on nanoparticles have not improved overall survival rates for cancer patients very much. Read more...


Techniques for RNA Detection in Live Cells

January 13, 2015 4:34 pm | by Martin J. Stoddart, Ph.D. Principal Scientist, Musculoskeletal Regeneration AO Research Institute Davos and Don Weldon R&D Manager EMD Millipore Corporation | Articles | Comments

RNA plays a key regulatory role in cell and tissue development as well as during disease progression. By studying RNA, researchers can advance the understanding of gene expression patterns and determine the roles of genomic elements in cellular function and dysfunction. Read more...


Merck Seeks New OK for Cancer Drug, Reorganization on Track

January 13, 2015 12:19 pm | by Linda A. Johnson, AP Business Writer - Associated Press | News | Comments

Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer. Read more...                        


Breakthrough on Chronic Pain

January 13, 2015 12:14 pm | by Harvard University | News | Comments

For the first time, scientists have found evidence of neuroinflammation in key regions of the brains of patients with chronic pain, according to a new study from Massachusetts General Hospital (MGH), a Harvard affiliate. Read more...                      


Prime Therapeutics Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs

January 13, 2015 12:08 pm | by Prime Therapeutics | News | Comments

People with Hepatitis C who are served by pharmacy benefit manager Prime Therapeutics LLC (Prime) will now have greater support for the treatment recommended by their physician. This is a result of new agreements between Prime and pharmaceutical companies Gilead Sciences and AbbVie. Read more...  


EGFR Inhibitor Extends OS Compared With Chemo

January 13, 2015 11:51 am | by Boehringer Ingelheim | News | Comments

Boehringer Ingelheim announced overall survival (OS) results were published in The Lancet Oncology from two independent Phase 3 clinical trials (LUX-Lung 3 and LUX-Lung 6) in epidermal growth factor receptor (EGFR) mutation-positive patients with metastatic non-small cell lung cancer (NSCLC). Read more...


Scientists Design Nicotine Vaccine

January 13, 2015 11:35 am | by The Scripps Institute | News | Comments

When a promising nicotine vaccine failed in clinical trials a few years ago, scientists from The Scripps Research Institute (TSRI) were determined to keep trying to help smokers overcome their addiction. Read more...                       


'Survival' Protein a Target in Drug Resistant Lymphomas

January 13, 2015 10:00 am | by Walter & Eliza Hall Institute of Medical Research | News | Comments

Researchers have discovered that targeting a cell ‘survival’ protein could help treat some lymphomas. Read more...                         



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.